Skip to main content

and
  1. No Access

    Article

    Positron emission tomography (PET) in the urooncological evaluation of the small pelvis

    Positron emission tomography (PET) with the use of (18F)2-fluoro-d-2-desoxyglucose (FDG) has been investigated to be a highly sensitive and specific imaging modality in the diagnostic of primary and recurrent tum...

    S. Machtens, J. Serth, A. Meyer, C. Kleinhorst, K.-J. Ommer in World Journal of Urology (2007)

  2. Article

    Neuroendocrine tumour of the mediastinum: fusion of 18F-FDG and 68Ga-DOTATOC PET/CT datasets demonstrates different degrees of differentiation

    C. von Falck, A. R. Boerner, M. Galanski in European Journal of Nuclear Medicine and M… (2007)

  3. No Access

    Article

    Positronenemissionstomographie (PET) zur Diagnostik und zum Therapiemonitoring bei urologischen Tumoren

    Die Positronenemissionstomographie (PET) unter Einsatz der (18F)2-Fluoro-D-2-desoxyglukose (FDG) hat sich bei zahlreichen nichturologischen Tumoren als eine Untersuchungsform mit hoher Sensitivität und Spezifität...

    Dr. S. Machtens, A. R. Boerner, M. Hofmann, W. H. Knapp, U. Jonas in Der Urologe, Ausgabe A (2004)

  4. No Access

    Article

    Pre-operative localisation of hyperfunctional parathyroid tissue with 11C-methionine PET

    Previous studies have shown high sensitivity of positron emission tomography (PET) with 11C-methionine in the pre-operative localisation of parathyroid adenoma and hyperplasia. Nonetheless, in secondary and terti...

    D. Otto, A. R. Boerner, M. Hofmann in European Journal of Nuclear Medicine and M… (2004)

  5. No Access

    Article

    Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients

    Visualisation of primary prostate cancer, its relapse and its metastases is a clinically relevant problem despite the availability of state-of-the-art methods such as CT, MRI, transrectal ultrasound and fluori...

    E. Fricke, S. Machtens, M. Hofmann in European Journal of Nuclear Medicine and M… (2003)

  6. No Access

    Article

    Pretherapeutic assessment of tumour metabolism using a dual tracer PET technique

    T. Brunkhorst, A. R. Boerner, S. Bergh in European Journal of Nuclear Medicine and M… (2002)

  7. No Access

    Article

    Optimal scan time for fluorine-18 fluorodeoxyglucose positron emission tomography in breast cancer

    Fluorine-18 fluorodeoxyglucose positron emission tomography (FDG PET) has proven useful in the differentiation of various tumour entities, including breast cancer. In patients with primary breast cancer we pe...

    A. R. Boerner, M. Weckesser, H. Herzog, T. Schmitz in European Journal of Nuclear Medicine (1999)